Literature DB >> 26787715

Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity.

Raymond M Johnson1, Robert C Brunham2.   

Abstract

For almost 2 decades, results from Chlamydia pathogenesis investigations have been conceptualized using a cytokine polarization narrative. Recent viral immunity studies identifying protective tissue-resident memory T cells (Trm) suggest an alternative paradigm based on localized immune networks. As Chlamydia vaccines enter the preclinical pipeline and, in the case of an attenuated trachoma vaccine, are given to human subjects, it may be useful to ask whether cytokine polarization is the appropriate framework for understanding and evaluating vaccine efficacy. In this review, we revisit C. trachomatis pathogenesis data from mice and humans using a Trm narrative and note a comfortable concordance with the Chlamydia pathogenesis literature.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787715      PMCID: PMC4807466          DOI: 10.1128/IAI.01378-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  A B220(-), CD19(-) population of B cells in the peripheral blood of quasimonoclonal mice.

Authors:  M Cascalho; J Wong; J Brown; H M Jäck; C Steinberg; M Wabl
Journal:  Int Immunol       Date:  2000-01       Impact factor: 4.823

2.  T cells and trachoma. Their role in cicatricial disease.

Authors:  M H Reacher; J Pe'er; P A Rapoza; J A Whittum-Hudson; H R Taylor
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

3.  Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae.

Authors:  N B Kiviat; J A Paavonen; P Wølner-Hanssen; C W Critchlow; W E Stamm; J Douglas; D A Eschenbach; L A Corey; K K Holmes
Journal:  Hum Pathol       Date:  1990-08       Impact factor: 3.466

4.  Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis.

Authors:  N B Kiviat; P Wølner-Hanssen; D A Eschenbach; J N Wasserheit; J A Paavonen; T A Bell; C W Critchlow; W E Stamm; D E Moore; K K Holmes
Journal:  Am J Surg Pathol       Date:  1990-02       Impact factor: 6.394

5.  Reduced levels of gamma-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections.

Authors:  J Debattista; P Timms; J Allan; J Allan
Journal:  Immunol Lett       Date:  2002-05-01       Impact factor: 3.685

6.  Infections, pregnancies, and infertility: perspectives on prevention. World Health Organization.

Authors: 
Journal:  Fertil Steril       Date:  1987-06       Impact factor: 7.329

7.  Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates.

Authors:  Harlan D Caldwell; Heidi Wood; Debbie Crane; Robin Bailey; Robert B Jones; David Mabey; Ian Maclean; Zeena Mohammed; Rosanna Peeling; Christine Roshick; Julius Schachter; Anthony W Solomon; Walter E Stamm; Robert J Suchland; Lacey Taylor; Sheila K West; Tom C Quinn; Robert J Belland; Grant McClarty
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs.

Authors:  N G Watkins; W J Hadlow; A B Moos; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.

Authors:  Raymond A Hawkins; Roger G Rank; Kathleen A Kelly
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes.

Authors:  N B Kiviat; J A Paavonen; J Brockway; C W Critchlow; R C Brunham; C E Stevens; W E Stamm; C C Kuo; T DeRouen; K K Holmes
Journal:  JAMA       Date:  1985-02-15       Impact factor: 56.272

View more
  26 in total

1.  Setting Sights on Chlamydia Immunity's Central Paradigm: Can We Hit a Moving Target?

Authors:  Rodolfo D Vicetti Miguel; Nirk E Quispe Calla; Thomas L Cherpes
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

2.  Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells.

Authors:  Saurabh Dixit; Rajnish Sahu; Richa Verma; Skyla Duncan; Guillermo H Giambartolomei; Shree R Singh; Vida A Dennis
Journal:  Biomaterials       Date:  2017-12-26       Impact factor: 12.479

3.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 4.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

Review 5.  Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Expert Rev Vaccines       Date:  2016-03-21       Impact factor: 5.217

6.  B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters.

Authors:  Raymond M Johnson; Hong Yu; Norma Olivares Strank; Karuna Karunakaran; Ying Zhu; Robert C Brunham
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 7.  Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Authors:  Rajnish Sahu; Richa Verma; Saurabh Dixit; Joseph U Igietseme; Carolyn M Black; Skyla Duncan; Shree R Singh; Vida A Dennis
Journal:  Expert Rev Vaccines       Date:  2018-02-06       Impact factor: 5.217

Review 8.  Immunopathogenesis of Chlamydial Infections.

Authors:  Ashlesh K Murthy; Weidang Li; Kyle H Ramsey
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

9.  2017: beginning of a new era for Chlamydia research in China and the rest of the world.

Authors:  Huizhou Fan; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-10-06       Impact factor: 2.700

10.  A Class II-Restricted CD8γ13 T-Cell Clone Protects During Chlamydia muridarum Genital Tract Infection.

Authors:  Raymond M Johnson; Norma Olivares-Strank; Gang Peng
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.